
Passage Bio Surges Ahead with Promising Gene Therapy Trial for Neurodegenerative Diseases
PHILADELPHIA, PA — In the competitive landscape of genetic medicine, one company is carving out a substantial niche. Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicine company with a …
Passage Bio Surges Ahead with Promising Gene Therapy Trial for Neurodegenerative Diseases Read More